CASI Pharmaceuticals appoints new president for China Operations

CASI Pharmaceuticals, a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effect...

October 8, 2018 | Monday | News
Cellular Bio gets NCI patent license for solid tumour immunotherapy

Cellular Biomedicine Group Inc. (CBMG), a clinical-stage biopharmaceutical firm engaged in the development of immunother...

October 5, 2018 | Friday | News
AXA Hong Kong, HKSH medical group enter into collaboration

AXA Hong Kong and HKSH Medical Group has entered into collaboration under which HKSH will be the first and biggest partn...

October 4, 2018 | Thursday | News
Hong Kong Department of Health approves Biktarvy

Singapore - Gilead Sciences announced that the Hong Kong Department of Health has approved Biktarvy (bictegravir 50mg/em...

October 3, 2018 | Wednesday | News
PAGD enters into an agreement with Grab

China's leading one-stop healthcare ecosystem platform, Ping An Good Doctor (PAGD) has announced that it has entered int...

October 3, 2018 | Wednesday | News
CANbridge Pharma submits NDA for NERLYNX in China

CANbridge Pharmaceutical Inc., a biopharmaceutical company developing Western drug candidates in China and North Asia, a...

October 2, 2018 | Tuesday | News
CSPC Pharma, Verastem sign license agreement for cancer treatment

Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cance...

October 1, 2018 | Monday | News
Novartis collaborates with Cellular Biomedicine for CAR-T Therapy

Cellular Biomedicine Group Inc. (CBMG) has entered into a strategic licensing and collaboration agreement with Novartis ...

September 28, 2018 | Friday | News
DiaMedica, Ahon Pharma sign license agreement for stroke treatment

Ahon Pharmaceutical Co Ltd., a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. Ltd, and DiaMedica Therapeutics I...

September 28, 2018 | Friday | News
Ganovo gets enrolled in basic medical Insurance of Tianjin

Ascletis Pharma Inc. announced that Ganovo (Danoprevir) has been enrolled in the Basic Medical Insurance of Tianjin...

September 27, 2018 | Thursday | News
WuXi, I-Mab collaborate to develop three bispecific antibodies

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...

September 27, 2018 | Thursday | News
Agilent to acquire ACEA Biosciences

Agilent Technologies Inc. has announced that it has signed a definitive agreement to acquire privately-owned ACEA Biosci...

September 26, 2018 | Wednesday | News
WeDoctor and Fullerton Health enter strategic partnership

Singapore - Fullerton Healthcare Corporation Limited, a leading vertically integrated healthcare platform in the As...

September 26, 2018 | Wednesday | News
Changchun High, New Technology form $200 M JV

China's biopharma firm Changchun High & New Technology Industries have teamed up with Iceland's drugmaker Alvotech t...

September 24, 2018 | Monday | News
Chinese scientists design new photoacoustic imaging technology

Researchers from Jinan University in China have developed a smart photoacoustic imaging approach by using a combination ...

September 21, 2018 | Friday | News
Innovent presents clinical data of Sintilimab

Innovent Biologics, a world-class China-based biopharmaceutical company that develops and commercializes high quality dr...

September 20, 2018 | Thursday | News
CPhI announces impact of change in global regulation on healthcare cost

CPhI Worldwide the world’s largest pharma event taking place in Madrid (9-11, October 2018) and org...

September 20, 2018 | Thursday | News
Huami launches Health Band 1S and Smart Wearable AI Chip

Huami Corporation, a biometric and activity data-driven company with significant expertise in smart wearable technology,...

September 19, 2018 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls